ARTICLE | Clinical News
U.S. Bioscience regulatory update
May 6, 1996 7:00 AM UTC
Canada approved Ethyol (amifostine) for use as a cytoprotective agent against the cumulative renal toxicities associated with cisplatin and the hematological toxicities associated with cyclophosphami...